Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$236M |
| 2 |
CVS Health
CVS
|
+$189M |
| 3 |
Mastercard
MA
|
+$155M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$112M |
| 5 |
Meta Platforms (Facebook)
META
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$814M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$763M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$315M |
| 4 |
SPDR Gold Trust
GLD
|
+$140M |
| 5 |
JD.com
JD
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 25.96% |
| 2 | Healthcare | 19.03% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
iShares Core MSCI EAFE ETF
IEFA
$196B
| $5.89M | 0.03% |
100,080
-475,225
| -83% | -$30.5M |
|
452
Evercore
EVR
$11.8B
| $5.89M | 0.02% |
+62,877
| New | +$6.7M |
|
453
Central Garden & Pet Co Class A
CENTA
$2.44B
| $5.84M | 0.02% |
182,489
+8,556
| +5% | +$282K |
|
454
Jefferies Financial Group
JEF
$13.1B
| $5.77M | 0.02% |
218,619
+191,135
| +695% | +$5.65M |
|
455
Crocs
CROX
$6.55B
| $5.7M | 0.02% |
+117,164
| New | +$7.11M |
|
456
Edgewell Personal Care
EPC
$1.31B
| $5.7M | 0.02% |
164,991
+7,636
| +5% | +$275K |
|
457
Corpay
CPAY
$25.7B
| $5.66M | 0.02% |
26,953
+22,280
| +477% | +$5.31M |
|
|
CVSA
458
Covista Inc
CVSA
$4.8B
| $5.63M | 0.02% |
156,658
-7,923
| -5% | -$250K |
|
459
Cracker Barrel
CBRL
$1.29B
| $5.57M | 0.02% |
66,673
+2,230
| +3% | +$232K |
|
460
Centene
CNC
$32.5B
| $5.43M | 0.02% |
64,156
+45,164
| +238% | +$3.75M |
|
|
AMED
461
DELISTED
Amedisys
AMED
| $5.4M | 0.02% |
51,353
+3,364
| +7% | +$430K |
|
462
Lear
LEA
$8.18B
| $5.39M | 0.02% |
42,827
+1,012
| +2% | +$133K |
|
463
Cal-Maine
CALM
$3.99B
| $5.37M | 0.02% |
108,644
+5,451
| +5% | +$277K |
|
464
Xylem
XYL
$28.1B
| $5.36M | 0.02% |
68,541
-43,526
| -39% | -$3.59M |
|
465
STAAR Surgical
STAA
$1.21B
| $5.36M | 0.02% |
75,490
+6,864
| +10% | +$442K |
|
466
Healthpeak Properties
DOC
$14.8B
| $5.35M | 0.02% |
206,383
+39,482
| +24% | +$1.2M |
|
467
Pediatrix Medical
MD
$2.2B
| $5.34M | 0.02% |
254,215
+129,933
| +105% | +$2.65M |
|
468
Kosmos Energy
KOS
$1.48B
| $5.32M | 0.02% |
+859,572
| New | +$6.2M |
|
469
Halliburton
HAL
$26.6B
| $5.3M | 0.02% |
169,134
+119,485
| +241% | +$4.45M |
|
470
Haemonetics
HAE
$4B
| $5.28M | 0.02% |
81,045
+7,552
| +10% | +$447K |
|
471
Zoom
ZM
$30.6B
| $5.28M | 0.02% |
+48,930
| New | +$5.16M |
|
|
CD
472
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $5.28M | 0.02% |
680,008
-2,693
| -0.4% | -$17.4K |
|
473
Norfolk Southern
NSC
$75.1B
| $5.27M | 0.02% |
23,196
+5,563
| +32% | +$1.37M |
|
474
Reliance Steel & Aluminium
RS
$21.6B
| $5.27M | 0.02% |
+31,004
| New | +$5.79M |
|
475
Sanmina
SANM
$10.9B
| $5.25M | 0.02% |
+128,870
| New | +$5.33M |
|
Similar funds
Ray Dalio's Q2 2022 Portfolio in Review
As of Q2 2022, Ray Dalio held 1,084 positions worth $23.6B, down 4.9% from $24.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ray Dalio deployed $1.38B of net new capital in Q2 2022, opening 116 new positions and adding to 613 existing holdings. Its largest new stake was Sea Limited: 459,240 shares worth $30.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $763M trimmed.
- Ray Dalio's largest Q2 2022 buy was Sea Limited: 459,240 shares worth $30.7M.
- Ray Dalio added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $236M increase.
- Ray Dalio's biggest Q2 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $763M.
- Ray Dalio fully exited Alibaba in Q2 2022, selling an estimated $814M.
- Ray Dalio's ten largest holdings make up 29% of its $23.6B portfolio in Q2 2022.
- Ray Dalio opened 116 new positions and closed 99 in Q2 2022.
- Ray Dalio's portfolio value fell 4.9% quarter-over-quarter to $23.6B.
Based on Bridgewater Associates's 13F filing for Q2 2022, filed 11 Aug 2022.